Zanamivir
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Zanamivir Product Information
Zanamivir is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Zanamivir. The product is supplied by Clearsynth under CAT No. CS-O-30822.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Zanamivir
CAS No.
139110-80-8
CAT No.
CS-O-30822
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C12H20N4O7
Molecular Weight
332.31
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Zanamivir is supplied with detailed characterization data compliant with regulatory guideline. Zanamivir can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Zanamivir.
Overview
"Zanamivir is a sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sial"
Synonyms
Zanamivir
Application Notes
"Zanamivir is a sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sial"
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.